Evidence map›Paper›PMID 31826007›Full record

ArticlePLoS biology2019

BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics.

Christian Hiepen, Jerome Jatzlau, Susanne Hildebrandt, Branka Kampfrath, Melis Goktas, Arunima Murgai, Jose Luis Cuellar Camacho, Rainer Haag, Clemens Ruppert, Gerhard Sengle and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 144 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Signaling pathways and targeted therapy for pulmonary hypertension.Signal transduction and targeted therapy · 2025
    Review
  13. Review
  14. Review
  15. Review
  16. Prodomain processing controls BMP-10 bioactivity and targeting to fibrillin-1 in latent conformation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Christian HiepenFreie Universität Berlin, Institute for Chemistry and Biochemistry, Berlin, Germany.ORCID 0000-0001-7345-6496
Jerome JatzlauFreie Universität Berlin, Institute for Chemistry and Biochemistry, Berlin, Germany.ORCID 0000-0002-1757-0267
Susanne HildebrandtFreie Universität Berlin, Institute for Chemistry and Biochemistry, Berlin, Germany.
Branka KampfrathFreie Universität Berlin, Institute for Chemistry and Biochemistry, Berlin, Germany.
Melis GoktasMax Planck Institute of Colloids and Interfaces, Mechano(bio)chemistry, Potsdam, Germany.ORCID 0000-0001-5616-8900
Arunima MurgaiFreie Universität Berlin, Institute for Chemistry and Biochemistry, Berlin, Germany.ORCID 0000-0001-9767-7402
Jose Luis Cuellar CamachoFreie Universität Berlin, Institute for Chemistry and Biochemistry, Berlin, Germany.
Rainer HaagFreie Universität Berlin, Institute for Chemistry and Biochemistry, Berlin, Germany.
Clemens RuppertUniversities of Giessen and Marburg Lung Center (UGMLC), Medical Clinic II, Justus Liebig University, Giessen, Germany.
Gerhard SengleUniversity of Cologne, Center for Biochemistry, Medical Faculty, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.ORCID 0000-0003-3932-1242
Elisabetta Ada Cavalcanti-AdamMax Planck Institute for Medical Research, Cellular Biophysics, Department of Physical Chemistry, Heidelberg, Germany.ORCID 0000-0003-0243-1552
Kerstin G BlankMax Planck Institute of Colloids and Interfaces, Mechano(bio)chemistry, Potsdam, Germany.ORCID 0000-0001-5410-6984
Petra KnausFreie Universität Berlin, Institute for Chemistry and Biochemistry, Berlin, Germany.ORCID 0000-0003-2492-1667
Freie Universität Berlin · DEMax Planck Institute of Colloids and Interfaces · DEJustus-Liebig-Universität Gießen · DEMax Planck Institute for Medical Research · DEMax Planck Institute for Molecular Genetics · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Balanced transforming growth factor-beta (TGFβ)/bone morphogenetic protein (BMP)-signaling is essential for tissue formation and homeostasis. While gain in TGFβ signaling is often found in diseases, the underlying cellular mechanisms remain poorly defined. Here we show that the receptor BMP type 2 (BMPR2) serves as a central gatekeeper of this balance, highlighted by its deregulation in diseases such as pulmonary arterial hypertension (PAH). We show that BMPR2 deficiency in endothelial cells (ECs) does not abolish pan-BMP-SMAD1/5 responses but instead favors the formation of mixed-heteromeric receptor complexes comprising BMPR1/TGFβR1/TGFβR2 that enable enhanced cellular responses toward TGFβ. These include canonical TGFβ-SMAD2/3 and lateral TGFβ-SMAD1/5 signaling as well as formation of mixed SMAD complexes. Moreover, BMPR2-deficient cells express genes indicative of altered biophysical properties, including up-regulation of extracellular matrix (ECM) proteins such as fibrillin-1 (FBN1) and of integrins. As such, we identified accumulation of ectopic FBN1 fibers remodeled with fibronectin (FN) in junctions of BMPR2-deficient ECs. Ectopic FBN1 deposits were also found in proximity to contractile intimal cells in pulmonary artery lesions of BMPR2-deficient heritable PAH (HPAH) patients. In BMPR2-deficient cells, we show that ectopic FBN1 is accompanied by active β1-integrin highly abundant in integrin-linked kinase (ILK) mechano-complexes at cell junctions. Increased integrin-dependent adhesion, spreading, and actomyosin-dependent contractility facilitates the retrieval of active TGFβ from its latent fibrillin-bound depots. We propose that loss of BMPR2 favors endothelial-to-mesenchymal transition (EndMT) allowing cells of myo-fibroblastic character to create a vicious feed-forward process leading to hyperactivated TGFβ signaling. In summary, our findings highlight a crucial role for BMPR2 as a gatekeeper of endothelial homeostasis protecting cells from increased TGFβ responses and integrin-mediated mechano-transduction.

Indexed as

AdipokinesBone Morphogenetic Protein Receptors, Type IICell LineEndothelial CellsEndothelium, VascularFibrillin-1Gene Expression RegulationHumansLungProtein Serine-Threonine KinasesPulmonary Arterial HypertensionPulmonary ArteryReceptors, Transforming Growth Factor betaScaffold Protein ILKSignal TransductionSmad ProteinsAdipokinesBMPR2 protein, humanBone Morphogenetic Protein Receptors, Type IIFBN1 protein, humanFibrillin-1Protein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaScaffold Protein ILKSmad ProteinsTransforming Growth Factor beta

Identifiers

PMID31826007
PMCPMC6927666
OpenAlexW2995426659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.